McKinsey & Company Settles Federal Investigation Over Purdue Pharma Involvement

McKinsey & Company Settles Federal Investigation Over Purdue Pharma Involvement

1 minute read
Updated 1 month ago

Settlement and Prosecution Agreement

has agreed to pay $650 million to settle a federal investigation into its work with , avoiding criminal prosecution under specific conditions for five years.

A former McKinsey senior partner will plead guilty to obstruction of justice for deleting documents related to the investigation, as part of the settlement terms.

Financial Repercussions and Broader Impact

Since 2021, McKinsey has paid approximately $765 million to state and local governments and $78 million to healthcare funds and insurance companies for its role in the opioid crisis.

Purdue Pharma, previously fined for its role in the crisis, faces an $8.3 billion penalty, largely waived if it completes a bankruptcy court settlement.
This is a beta feature. We cannot guarantee the accuracy or quality of responses.